RECURRENT MYELODYSPLASTIC SYNDROME
Clinical trials for RECURRENT MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for RECURRENT MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough MDS: drug trio targets resistant cancer cells
Disease control CompletedThis study tested a three-drug combination (navitoclax, venetoclax, and decitabine) in 6 adults with high-risk myelodysplastic syndrome (MDS) that came back or didn't respond to standard therapy. The goal was to find the safest dose and see if the combo could shrink or control th…
Matched conditions: RECURRENT MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New combo tackles relapsed leukemia after stem cell transplant
Disease control CompletedThis study tested a drug called guadecitabine combined with donor lymphocyte infusions in 55 patients whose acute myeloid leukemia or myelodysplastic syndrome came back after a stem cell transplant. The goal was to see if the drug could help the donor immune cells fight the cance…
Matched conditions: RECURRENT MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC